XenoPort to Present at the 2014 Wells Fargo Healthcare Conference
June 09 2014 - 10:00AM
Business Wire
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will
provide access via the World Wide Web to its presentation at the
2014 Wells Fargo Healthcare Conference. The live presentation will
occur at 11:25 a.m. Pacific Time (2:25 p.m. Eastern Time) on
Wednesday, June 18, 2014. A replay of the presentation will also be
available.
To access the live presentation via the Web, please go to
www.XenoPort.com. Please connect to the Web site at least 15
minutes prior to the live presentation to ensure adequate time for
any software downloads that may be necessary to listen to the
Webcast.
A replay of the Webcast can be accessed for a minimum of one
month and will be available approximately 24 hours after the live
presentation.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on
developing and commercializing a portfolio of internally discovered
product candidates for the potential treatment of neurological
disorders. XenoPort is currently commercializing HORIZANT®
(gabapentin enacarbil) Extended-Release Tablets in the United
States and developing its novel fumaric acid ester product
candidate, XP23829, as a potential treatment for patients with
moderate-to-severe chronic plaque type psoriasis and/or relapsing
forms of multiple sclerosis. REGNITE® (gabapentin enacarbil)
Extended-Release Tablets is being marketed in Japan by Astellas
Pharma Inc. XenoPort's pipeline of product candidates also includes
a potential treatment for patients with Parkinson's disease.
To learn more about XenoPort, please visit the website at
www.XenoPort.com.
XNPT2G
XenoPort, Inc.Jackie Cossmon, 408-616-7220ir@XenoPort.com
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Apr 2023 to Apr 2024